These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 19850448)

  • 1. Short-term impact of the switch from immediate-release to extended-release oxcarbazepine in epilepsy patients on high dosages.
    Steinhoff BJ; Wendling AS
    Epilepsy Res; 2009 Dec; 87(2-3):256-9. PubMed ID: 19850448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Slow release versus immediate release oxcarbazepine in difficult-to-treat focal epilepsy: a multicenter, randomized, open, controlled, parallel group phase III study].
    Steinhoff BJ; Stefan H; Schulze-Bonhage A; Hueber R; Paulus W; Wangemann M; Elger CE
    Nervenarzt; 2012 Oct; 83(10):1292-9. PubMed ID: 22850688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between mono-hydroxy-carbazepine serum concentrations and adverse effects in patients on oxcarbazepine monotherapy.
    Sattler A; Schaefer M; May TW
    Seizure; 2015 Sep; 31():149-54. PubMed ID: 26362393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carbamazepine extended-release capsules vs. oxcarbazepine: computer simulations of the effect of missed doses on drug plasma concentrations.
    Ahmad A; Garnett WR
    Curr Med Res Opin; 2005 Sep; 21(9):1363-8. PubMed ID: 16197654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of the monohydroxy derivative of oxcarbazepine and its enantiomers after a single intravenous dose given as racemate compared with a single oral dose of oxcarbazepine.
    Flesch G; Czendlik C; Renard D; Lloyd P
    Drug Metab Dispos; 2011 Jun; 39(6):1103-10. PubMed ID: 21389120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between serum mono-hydroxy-carbazepine concentrations and adverse effects in patients with epilepsy on high-dose oxcarbazepine therapy.
    Striano S; Striano P; Di Nocera P; Italiano D; Fasiello C; Ruosi P; Bilo L; Pisani F
    Epilepsy Res; 2006 May; 69(2):170-6. PubMed ID: 16515857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overnight switching from oxcarbazepine to eslicarbazepine acetate: an observational study.
    Schmid E; Kuchukhidze G; Kirschner M; Leitinger M; Höfler J; Rohracher A; Kalss G; Wendling AS; Steinhoff BJ; Trinka E
    Acta Neurol Scand; 2017 Apr; 135(4):449-453. PubMed ID: 27444636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Abrupt switch from extended-release oxcarbazepine to eslicarbazepine acetate].
    Steinhoff BJ; Trinka E; Wendling AS
    Nervenarzt; 2011 Jun; 82(6):764-7. PubMed ID: 21052972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxcarbazepine extended-release formulation in epilepsy.
    Steinhoff BJ
    Expert Rev Clin Pharmacol; 2009 Mar; 2(2):155-62. PubMed ID: 24410646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved tolerability and efficacy in epilepsy patients with extended-release carbamazepine.
    Ficker DM; Privitera M; Krauss G; Kanner A; Moore JL; Glauser T
    Neurology; 2005 Aug; 65(4):593-5. PubMed ID: 16116122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical feasibility of immediate overnight switching from slow-release carbamazepine to oxcarbazepine in Korean patients with refractory partial epilepsy.
    Lee SA; Heo K; Kim WJ; Song HK; Kim SE; Kim SH; No SK; Lee BI
    Seizure; 2010 Jul; 19(6):356-8. PubMed ID: 20538492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved CNS tolerability following conversion from immediate- to extended-release carbamazepine.
    Miller AD; Krauss GL; Hamzeh FM
    Acta Neurol Scand; 2004 Jun; 109(6):374-7. PubMed ID: 15147458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Usefulness of oral loading of oxcarbazepine suspension in selected patients with epilepsy.
    Kim DW; Gu N; Lee H; Jang IJ; Chu K; Yu KS; Cho JY; Yoon SH; Na HJ; Lee SK
    Int J Clin Pharmacol Ther; 2013 Oct; 51(10):780-6. PubMed ID: 23849326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in the disposition of oxcarbazepine and its metabolites during pregnancy and the puerperium.
    Mazzucchelli I; Onat FY; Ozkara C; Atakli D; Specchio LM; Neve AL; Gatti G; Perucca E
    Epilepsia; 2006 Mar; 47(3):504-9. PubMed ID: 16529613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxcarbazepine and adverse events: impact of age, dosage, metabolite serum concentrations and concomitant antiepileptic therapy.
    Ortenzi A; Paggi A; Foschi N; Sabbatini D; Pistoli E
    Funct Neurol; 2008; 23(2):97-100. PubMed ID: 18671911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors of oxcarbazepine-induced hyponatremia in patients with epilepsy.
    Lin CH; Lu CH; Wang FJ; Tsai MH; Chang WN; Tsai NW; Lai SL; Tseng YL; Chuang YC
    Clin Neuropharmacol; 2010; 33(6):293-6. PubMed ID: 20881597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Open prospective study on oxcarbazepine in epilepsy in children: a preliminary report.
    Franzoni E; Garone C; Sarajlija J; Gualandi S; Malaspina E; Cecconi I; Moscano FC; Marchiani V
    Seizure; 2006 Jul; 15(5):292-8. PubMed ID: 16554175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of low to moderate doses of oxcarbazepine in adult patients with newly diagnosed partial epilepsy.
    Zou XM; Chen JN; An DM; Hao NY; Hong Z; Hao XT; Rao P; Zhou D
    Seizure; 2015 Jul; 29():81-5. PubMed ID: 26076847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High and low dosage oxcarbazepine versus naltrexone for the prevention of relapse in alcohol-dependent patients.
    Martinotti G; Di Nicola M; Romanelli R; Andreoli S; Pozzi G; Moroni N; Janiri L
    Hum Psychopharmacol; 2007 Apr; 22(3):149-56. PubMed ID: 17397097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Ad hoc change from carbamazepine to oxcarbazepine--effectiveness and tolerance. A retrospective analysis].
    Homberg V; Kowalik A; Schulze-Bonhage A
    Nervenarzt; 2001 Dec; 72(12):918-23. PubMed ID: 11789435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.